ARMISTEAD LANDON WELLFORD M.D. NPI 1568553733

NPI Details

Armistead Landon Wellford, M.D. is a cardiovascular disease internal medicine in San Antonio, TX with 41 years of experience. The provider is an internist who specializes in diseases of the heart and blood vessels and manages complex cardiac conditions such as heart attacks and life-threatening, abnormal heartbeat rhythms. Armistead Landon Wellford, M.D. NPI is 1568553733. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

Education
Medical School: UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL SCHOOL OF MEDICINE
Graduation Year:1984

The provider's business location address is:

1933 NE LOOP 410
SAN ANTONIO, TX
ZIP 78217
Phone: (210) 804-6000
Fax: (210) 804-6069

The NPI 1568553733 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Blood test, comprehensive group of blood chemicals (HCPCS:80053)
• Blood test, lipids (cholesterol and triglycerides) (HCPCS:80061)
• Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
• Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
• Hemoglobin a1c level (HCPCS:83036)
• Urine microalbumin (protein) level (HCPCS:82043)
• Thyroxine (thyroid chemical), free (HCPCS:84439)
• Creatinine level to test for kidney function or muscle injury (HCPCS:82570)
• Blood test, basic group of blood chemicals (calcium, total) (HCPCS:80048)
• Vitamin d-3 level (HCPCS:82306)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report (HCPCS:93000)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Liver enzyme (sgpt), level (HCPCS:84460)
• Psa (prostate specific antigen) measurement, total (HCPCS:84153)
• Cyanocobalamin (vitamin b-12) level (HCPCS:82607)
• Ferritin (blood protein) level (HCPCS:82728)
• Iron level (HCPCS:83540)
• Iron binding capacity (HCPCS:83550)
• Liver function blood test panel (HCPCS:80076)
• Thyroid hormone, t3 measurement, free (HCPCS:84481)
• Hepatitis c antibody measurement (HCPCS:86803)
• Prostate cancer screening; prostate specific antigen test (psa) (HCPCS:G0103)
• Folic acid level, serum (HCPCS:82746)
• Injection, regadenoson, 0.1 mg (HCPCS:J2785)
• Creatine kinase (cardiac enzyme) level, total (HCPCS:82550)
• Uric acid level, blood (HCPCS:84550)
• Insertion of needle into vein for collection of blood sample (HCPCS:36415)
• Nuclear medicine studies of heart muscle at rest and with stress and spect (HCPCS:78452)
• Ultrasound of heart with color-depicted blood flow, rate, direction and valve function (HCPCS:93306)
• Complete blood cell count (red cells, white blood cell, platelets), automated test (HCPCS:85027)
• Red blood cell sedimentation rate, to detect inflammation, automated (HCPCS:85652)
• Magnesium level (HCPCS:83735)
• Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician (HCPCS:93015)
• Blood test, clotting time (HCPCS:85610)
• Technetium tc-99m sestamibi, diagnostic, per study dose (HCPCS:A9500)
• Phosphate level (HCPCS:84100)
• Kidney function blood test panel (HCPCS:80069)
• Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician (HCPCS:93018)
• Lipase (fat enzyme) level (HCPCS:83690)
• Heart rhythm review, and interpretation of continous external ekg over more than 48 hours up to 7 days (HCPCS:93244)
• Heart rhythm recording continous external ekg over more than 48 hours up to 7 days (HCPCS:93242)
• Amylase (enzyme) level (HCPCS:82150)
• Red blood count, automated test (HCPCS:85045)
• Follow-up hospital inpatient care per day, typically 35 minutes (HCPCS:99233)
• Follow-up hospital inpatient care per day, typically 25 minutes (HCPCS:99232)
• Hepatitis c antibody screening, for individual at high risk and other covered indication(s) (HCPCS:G0472)
• Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
• Ultrasound of both sides of head and neck blood flow (HCPCS:93880)
• New patient office or other outpatient visit, 30-44 minutes (HCPCS:99203)
• New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
• Measurement of hepatitis a antibody (HCPCS:86708)
• Detection test by immunoassay technique for hiv-1 antigen and hiv-1 and hiv-2 antibodies (HCPCS:87389)
• Lactate dehydrogenase (enzyme) level (HCPCS:83615)
• Acute hepatitis panel (HCPCS:80074)
• Ultrasound of heart with color-depicted blood flow, rate, direction and valve function (HCPCS:93306)
• Bilirubin level, direct (HCPCS:82248)
• Telephone medical discussion with physician, 5-10 minutes (HCPCS:99441)
• Hepatitis b surface antibody measurement (HCPCS:86706)
• Detection test by immunoassay technique for hepatitis b surface antigen (HCPCS:87340)
• Cholesterol level (HCPCS:82465)
• Hepatitis b core antibody measurement (HCPCS:86704)
• Hdl cholesterol level (HCPCS:83718)
• Ldl cholesterol level (HCPCS:83721)
• Telephone medical discussion with physician, 11-20 minutes (HCPCS:99442)

The enumeration date for this NPI number is 9/27/2006 and was last updated on 12/8/2007.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.